Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
11.12
+0.07 (0.63%)
At close: May 13, 2026, 4:00 PM EDT
11.09
-0.03 (-0.27%)
After-hours: May 13, 2026, 7:59 PM EDT

Zevra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
657509448272159305
Market Cap Growth
67.99%13.81%64.53%71.60%-48.00%499.98%
Enterprise Value
457.89381.2437.99247.5489.34193.79
Last Close Price
11.128.968.346.554.598.71
PE Ratio
5.606.64-3.66-5.04-5.88-4.13
Forward PE
17.1319.15----
PS Ratio
5.384.7818.969.9115.1610.64
PB Ratio
3.193.2911.284.392.112.40
P/TBV Ratio
3.123.329.733.752.112.04
P/FCF Ratio
54.80-209.38-6.43-8.04-8.4329.50
P/OCF Ratio
51.49-318.79-6.43-8.11-8.4729.21
EV/Sales Ratio
3.743.5818.559.018.546.76
EV/EBITDA Ratio
35.96-6.47-5.43-5.09-2.1524.27
EV/EBIT Ratio
45.97-6.06-5.03-4.99-2.1025.07
EV/FCF Ratio
38.17-156.68-6.29-7.32-4.7518.75
Debt / Equity Ratio
0.000.411.510.700.180.01
Debt / EBITDA Ratio
-0.22-1.07-0.75-0.90-0.340.20
Debt / FCF Ratio
0.10-25.98-0.87-1.29-0.750.15
Net Debt / Equity Ratio
-0.97-0.83-0.23-0.39-0.92-0.87
Net Debt / EBITDA Ratio
38.012.170.110.491.65-13.87
Net Debt / FCF Ratio
-16.6352.530.130.713.65-10.71
Asset Turnover
0.430.460.130.190.080.40
Inventory Turnover
8.418.897.53---
Quick Ratio
4.745.462.351.157.5826.92
Current Ratio
4.895.682.531.187.7227.20
Return on Equity (ROE)
68.04%85.66%-207.75%-67.27%-41.11%-28.18%
Return on Assets (ROA)
-3.05%-28.28%-41.18%-34.49%-34.88%10.68%
Return on Invested Capital (ROIC)
-15.02%-86.35%-90.57%-96.78%-197.33%85.98%
Return on Capital Employed (ROCE)
-3.36%-32.32%-71.71%-49.13%-36.64%11.68%
Earnings Yield
17.80%15.07%-27.34%-19.85%-16.99%-24.22%
FCF Yield
1.82%-0.48%-15.56%-12.44%-11.86%3.39%
Buyback Yield / Dilution
-19.19%-23.81%-30.46%-2.79%-15.87%-647.71%
Total Shareholder Return
-19.19%-23.81%-30.46%-2.79%-15.87%-647.71%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q